Literature DB >> 17971076

Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments.

U Rüb1, E R Brunt, K Seidel, K Gierga, C M Mooy, M Kettner, C Van Broeckhoven, I Bechmann, A R La Spada, L Schöls, W den Dunnen, R A I de Vos, T Deller.   

Abstract

Spinocerebellar ataxia type 7 (SCA7) represents a rare and severe autosomal dominantly inherited ataxic disorder and is among the known CAG-repeat, or polyglutamine, diseases. In contrast to other currently known autosomal dominantly inherited ataxic disorders, SCA7 may manifest itself with different clinical courses. Because the degenerative changes evolving during these different clinical courses are not well known, many neurological disease symptoms still are unexplained. We performed an initial pathoanatomical study on unconventional thick tissue sections of the brain of a clinically diagnosed and genetically confirmed adult-onset SCA7 patient with progressive visual impairments. In this patient we observed loss of myelinated fibres in distinct central nervous fibre tracts, and widespread degeneration of the cerebellum, telencephalon, diencephalon and lower brainstem. These degenerative changes offer appropriate explanations for a variety of less-understood neurological symptoms in adult-onset SCA7 patients with visual impairments: gait, stance and limb ataxia, falls, dysarthria, dysphagia, pyramidal signs, Parkinsonian features, writing problems, impairments of saccades and smooth pursuits, altered pupillary functions, somatosensory deficits, auditory deficits and mental impairments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971076     DOI: 10.1111/j.1365-2990.2007.00882.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  7 in total

1.  Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3).

Authors:  W Scherzed; E R Brunt; H Heinsen; R A de Vos; K Seidel; K Bürk; L Schöls; G Auburger; D Del Turco; T Deller; H W Korf; W F den Dunnen; U Rüb
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

Review 2.  Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.

Authors:  Arun Kumar Verma; Eshan Khan; Sonali R Bhagwat; Amit Kumar
Journal:  Mol Neurobiol       Date:  2019-08-09       Impact factor: 5.590

Review 3.  Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

Authors:  Anna Niewiadomska-Cimicka; Yvon Trottier
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

4.  Spinocerebellar ataxia 7 (SCA7) in Indian population: predilection of ATXN7-CAG expansion mutation in an ethnic population.

Authors:  Mohammed Faruq; Achal Kumar Srivastava; Suman Singh; Rohit Gupta; Tanuj Dada; Ajay Garg; Madhuri Behari; Mitali Mukerji
Journal:  Indian J Med Res       Date:  2015-02       Impact factor: 2.375

Review 5.  Central ocular motor disorders, including gaze palsy and nystagmus.

Authors:  M Strupp; O Kremmyda; C Adamczyk; N Böttcher; C Muth; C W Yip; T Bremova
Journal:  J Neurol       Date:  2014-09       Impact factor: 4.849

6.  Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot study.

Authors:  Gail L Widener; Nicole Conley; Sarah Whiteford; Jason Gee; Anthony Harrell; Cynthia Gibson-Horn; Valerie Block; Diane D Allen
Journal:  Physiother Res Int       Date:  2019-11-20

7.  Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7.

Authors:  Anna F Fusco; Logan A Pucci; Pawel M Switonski; Debolina D Biswas; Angela L McCall; Amanda F Kahn; Justin S Dhindsa; Laura M Strickland; Albert R La Spada; Mai K ElMallah
Journal:  Dis Model Mech       Date:  2021-07-20       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.